Wakabayashi Kanako, Nakagawa Hiroshi, Tamura Ai, Koshiba Shoko, Hoshijima Kazuyuki, Komada Masayuki, Ishikawa Toshihisa
Department of Biomolecular Engineering, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama 226-8501, Japan.
J Biol Chem. 2007 Sep 21;282(38):27841-6. doi: 10.1074/jbc.C700133200. Epub 2007 Aug 8.
Human ABCG2 belongs to the ATP-binding cassette (ABC) transporter family and plays an important role in various biological reactions, such as xenobiotic elimination and homeostasis of protoporphyrin. We previously reported that ABCG2 exists in the plasma membrane as a homodimer bound via a disulfide bond at Cys-603. In the present study, we examined the importance of an intramolecular disulfide bond for stability of the ABCG2 protein. Substitution of either Cys-592 or Cys-608 located in the extracellular loop to glycine resulted in a significant decrease in protein levels of ABCG2 when expressed in Flp-In-293 cells. Interestingly, the protein levels of those ABCG2 variants were remarkably enhanced by treatment with the proteasome inhibitor MG132. Concomitantly, increases in ubiquitinated forms of those variant proteins were detected by immunoprecipitation. In contrast, neither the protein level nor the ubiquitinated state of the ABCG2 wild-type (WT) was affected by MG132 treatment. Ubiquitin-mediated protein degradation is suggested to be involved in degradation of misfolded ABCG2 proteins lacking the intramolecular disulfide bond. On the other hand, the protein level of ABCG2 WT increased more than 4-fold when cells were treated with bafilomycin A(1), which inhibits lysosomal degradation, whereas the C592G or C608G variant was little affected by the same treatment. These results strongly suggest that two distinct pathways exist for protein degradation of ABCG2 WT and mutants lacking the intramolecular disulfide bond. Namely, the WT ABCG2 is degraded in lysosomes, and the misfolded ABCG2 lacking intramolecular disulfide bond undergoes ubiquitin-mediated protein degradation in proteasomes.
人类ABCG2属于ATP结合盒(ABC)转运蛋白家族,在多种生物学反应中发挥重要作用,如异生物质消除和原卟啉的稳态。我们之前报道过ABCG2以同二聚体形式存在于质膜中,通过半胱氨酸603处的二硫键结合。在本研究中,我们研究了分子内二硫键对ABCG2蛋白稳定性的重要性。将位于细胞外环的半胱氨酸592或半胱氨酸608替换为甘氨酸,导致在Flp-In-293细胞中表达时ABCG2的蛋白水平显著降低。有趣的是,用蛋白酶体抑制剂MG132处理可显著提高这些ABCG2变体的蛋白水平。同时,通过免疫沉淀检测到这些变体蛋白的泛素化形式增加。相比之下,MG132处理对ABCG2野生型(WT)的蛋白水平和泛素化状态均无影响。提示泛素介导的蛋白质降解参与了缺乏分子内二硫键的错误折叠ABCG2蛋白的降解。另一方面,用抑制溶酶体降解的巴弗洛霉素A(1)处理细胞时,ABCG2 WT的蛋白水平增加了4倍以上,而C592G或C608G变体受相同处理的影响很小。这些结果强烈表明,ABCG2 WT和缺乏分子内二硫键的突变体存在两种不同的蛋白质降解途径。即,WT ABCG2在溶酶体中降解,而缺乏分子内二硫键的错误折叠ABCG2在蛋白酶体中经历泛素介导的蛋白质降解。